Dr. Richard Porter brings over 20 years of experience working across multiple therapeutic areas in the pharmaceutical and biotech industries. Dr. Porter spent over 14 years in total at Roche in positions of increasing responsibility, most recently as the Global Head of Operations Management for Neuroscience Ophthalmology and Rare Diseases directing the strategic and operational activities of the department. Dr. Porter has also served as a Product General Manager of the Emerging Business Unit at Shire Pharmaceuticals, and held scientific leadership positions at Vernalis and ASTRA. He brings extensive experience at both an operational and strategic level having brought multiple projects through development. Dr. Porter received his academic training at the University of Southampton and postdoctoral at the University of Oxford (United Kingdom) and at the University of Rochester (United States).
Business